The AdVance and AdVanceXP male sling in urinary incontinence: is there a difference?
Purpose To compare the efficacy and perioperative complications of the AdVanceXP with the original AdVance male sling. Methods We retrospectively enrolled 109 patients with an AdVance and 185 patients with an AdVanceXP male sling. The baseline characteristics and complication rates were analyzed ret...
Gespeichert in:
Veröffentlicht in: | World journal of urology 2018-10, Vol.36 (10), p.1657-1662 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1662 |
---|---|
container_issue | 10 |
container_start_page | 1657 |
container_title | World journal of urology |
container_volume | 36 |
creator | Hüsch, Tanja Kretschmer, Alexander Thomsen, Frauke Kronlachner, Dominik Kurosch, Martin Obaje, Alice Anding, Ralf Kirschner-Hermanns, Ruth Pottek, Tobias Rose, Achim Olianas, Roberto Lusuardi, Lukas Friedl, Alexander Homberg, Roland Pfitzenmaier, Jesco Queissert, Fabian Naumann, Carsten M. Schweiger, Josef Wotzka, Carola Nyarangi-Dix, Joanne Brehmer, Bernhard Abdunnur, Rudi Loertzer, Hagen Ulm, Kurt Hübner, Wilhelm Bauer, Ricarda M. Haferkamp, Axel |
description | Purpose
To compare the efficacy and perioperative complications of the AdVanceXP with the original AdVance male sling.
Methods
We retrospectively enrolled 109 patients with an AdVance and 185 patients with an AdVanceXP male sling. The baseline characteristics and complication rates were analyzed retrospectively. Functional outcome and quality of life were evaluated prospectively by standardized, validated questionnaires. The Chi
2
-test for categorical and Mann–Whitney
U
test for continuous variables were performed to identify heterogeneity between the groups.
Results
Regarding operation time, there was no significant difference between the slings (
p
= 0.146). The complication rates were comparable in both groups except for postoperative urinary retention. This occurred significantly more often in patients with the AdVanceXP (
p
= 0.042). During follow-up, no differences could be identified regarding ICIQ-SF, PGI or I-QoL or number of pad usage.
Conclusions
The AdVance and AdVanceXP are safe and effective treatment options for male stress urinary incontinence. However, the innovations of the AdVanceXP sling did not demonstrate a superiority over the original AdVance sling regarding functional outcome. |
doi_str_mv | 10.1007/s00345-018-2316-5 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2035242476</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>952253431</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-697443928861c8abcbc1f0c241ed8108aee4622f017e7ff9eae813c30506b6423</originalsourceid><addsrcrecordid>eNp1kEFLJDEQhYOs6Kz6A7xI2JOXXiuVdJLei4joriDoYRRvIZOu1paetCbTB_-9kdEVBE95JN97VXmM7Qv4LQDMUQaQqq5A2Aql0FW9wWZCSVlZg_oHm4FBVanGym32M-dHAGE01FtsGxuD1mg1Y_P5A_GT9tbHQNzH9kPfXfOlH4jnoY_3vI98Sn306aXIMMZVH6lAf3if-eqBUrHytu-6osr18S7b7PyQae_93GE352fz03_V5dXfi9OTyypII1aVboxSskFrtQjWL8IiiA4CKkGtFWA9kdKIXVmbTNc15MkKGSTUoBdaodxhh-vcpzQ-T5RXbtnnQMPgI41TdgiyRoXK6IL--oI-jlOKZTuHCGjqRjQFEmsopDHnRJ17Sv2y_NoJcG-Nu3XjrjTu3hp3dfEcvAdPiyW1_x0fFRcA10AuT_Ge0ufk71NfAUlDiRs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>220275919</pqid></control><display><type>article</type><title>The AdVance and AdVanceXP male sling in urinary incontinence: is there a difference?</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Hüsch, Tanja ; Kretschmer, Alexander ; Thomsen, Frauke ; Kronlachner, Dominik ; Kurosch, Martin ; Obaje, Alice ; Anding, Ralf ; Kirschner-Hermanns, Ruth ; Pottek, Tobias ; Rose, Achim ; Olianas, Roberto ; Lusuardi, Lukas ; Friedl, Alexander ; Homberg, Roland ; Pfitzenmaier, Jesco ; Queissert, Fabian ; Naumann, Carsten M. ; Schweiger, Josef ; Wotzka, Carola ; Nyarangi-Dix, Joanne ; Brehmer, Bernhard ; Abdunnur, Rudi ; Loertzer, Hagen ; Ulm, Kurt ; Hübner, Wilhelm ; Bauer, Ricarda M. ; Haferkamp, Axel</creator><creatorcontrib>Hüsch, Tanja ; Kretschmer, Alexander ; Thomsen, Frauke ; Kronlachner, Dominik ; Kurosch, Martin ; Obaje, Alice ; Anding, Ralf ; Kirschner-Hermanns, Ruth ; Pottek, Tobias ; Rose, Achim ; Olianas, Roberto ; Lusuardi, Lukas ; Friedl, Alexander ; Homberg, Roland ; Pfitzenmaier, Jesco ; Queissert, Fabian ; Naumann, Carsten M. ; Schweiger, Josef ; Wotzka, Carola ; Nyarangi-Dix, Joanne ; Brehmer, Bernhard ; Abdunnur, Rudi ; Loertzer, Hagen ; Ulm, Kurt ; Hübner, Wilhelm ; Bauer, Ricarda M. ; Haferkamp, Axel</creatorcontrib><description>Purpose
To compare the efficacy and perioperative complications of the AdVanceXP with the original AdVance male sling.
Methods
We retrospectively enrolled 109 patients with an AdVance and 185 patients with an AdVanceXP male sling. The baseline characteristics and complication rates were analyzed retrospectively. Functional outcome and quality of life were evaluated prospectively by standardized, validated questionnaires. The Chi
2
-test for categorical and Mann–Whitney
U
test for continuous variables were performed to identify heterogeneity between the groups.
Results
Regarding operation time, there was no significant difference between the slings (
p
= 0.146). The complication rates were comparable in both groups except for postoperative urinary retention. This occurred significantly more often in patients with the AdVanceXP (
p
= 0.042). During follow-up, no differences could be identified regarding ICIQ-SF, PGI or I-QoL or number of pad usage.
Conclusions
The AdVance and AdVanceXP are safe and effective treatment options for male stress urinary incontinence. However, the innovations of the AdVanceXP sling did not demonstrate a superiority over the original AdVance sling regarding functional outcome.</description><identifier>ISSN: 0724-4983</identifier><identifier>EISSN: 1433-8726</identifier><identifier>DOI: 10.1007/s00345-018-2316-5</identifier><identifier>PMID: 29728764</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Aged ; Chi-Square Distribution ; Follow-Up Studies ; Humans ; Male ; Medicine ; Medicine & Public Health ; Nephrology ; Oncology ; Operative Time ; Original Article ; Patients ; Prospective Studies ; Quality of Life ; Retrospective Studies ; Suburethral Slings - adverse effects ; Suburethral Slings - classification ; Treatment Outcome ; Urinary incontinence ; Urinary Incontinence, Stress - therapy ; Urology</subject><ispartof>World journal of urology, 2018-10, Vol.36 (10), p.1657-1662</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2018</rights><rights>World Journal of Urology is a copyright of Springer, (2018). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-697443928861c8abcbc1f0c241ed8108aee4622f017e7ff9eae813c30506b6423</citedby><cites>FETCH-LOGICAL-c371t-697443928861c8abcbc1f0c241ed8108aee4622f017e7ff9eae813c30506b6423</cites><orcidid>0000-0002-7872-5496</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00345-018-2316-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00345-018-2316-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,782,786,27931,27932,41495,42564,51326</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29728764$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hüsch, Tanja</creatorcontrib><creatorcontrib>Kretschmer, Alexander</creatorcontrib><creatorcontrib>Thomsen, Frauke</creatorcontrib><creatorcontrib>Kronlachner, Dominik</creatorcontrib><creatorcontrib>Kurosch, Martin</creatorcontrib><creatorcontrib>Obaje, Alice</creatorcontrib><creatorcontrib>Anding, Ralf</creatorcontrib><creatorcontrib>Kirschner-Hermanns, Ruth</creatorcontrib><creatorcontrib>Pottek, Tobias</creatorcontrib><creatorcontrib>Rose, Achim</creatorcontrib><creatorcontrib>Olianas, Roberto</creatorcontrib><creatorcontrib>Lusuardi, Lukas</creatorcontrib><creatorcontrib>Friedl, Alexander</creatorcontrib><creatorcontrib>Homberg, Roland</creatorcontrib><creatorcontrib>Pfitzenmaier, Jesco</creatorcontrib><creatorcontrib>Queissert, Fabian</creatorcontrib><creatorcontrib>Naumann, Carsten M.</creatorcontrib><creatorcontrib>Schweiger, Josef</creatorcontrib><creatorcontrib>Wotzka, Carola</creatorcontrib><creatorcontrib>Nyarangi-Dix, Joanne</creatorcontrib><creatorcontrib>Brehmer, Bernhard</creatorcontrib><creatorcontrib>Abdunnur, Rudi</creatorcontrib><creatorcontrib>Loertzer, Hagen</creatorcontrib><creatorcontrib>Ulm, Kurt</creatorcontrib><creatorcontrib>Hübner, Wilhelm</creatorcontrib><creatorcontrib>Bauer, Ricarda M.</creatorcontrib><creatorcontrib>Haferkamp, Axel</creatorcontrib><title>The AdVance and AdVanceXP male sling in urinary incontinence: is there a difference?</title><title>World journal of urology</title><addtitle>World J Urol</addtitle><addtitle>World J Urol</addtitle><description>Purpose
To compare the efficacy and perioperative complications of the AdVanceXP with the original AdVance male sling.
Methods
We retrospectively enrolled 109 patients with an AdVance and 185 patients with an AdVanceXP male sling. The baseline characteristics and complication rates were analyzed retrospectively. Functional outcome and quality of life were evaluated prospectively by standardized, validated questionnaires. The Chi
2
-test for categorical and Mann–Whitney
U
test for continuous variables were performed to identify heterogeneity between the groups.
Results
Regarding operation time, there was no significant difference between the slings (
p
= 0.146). The complication rates were comparable in both groups except for postoperative urinary retention. This occurred significantly more often in patients with the AdVanceXP (
p
= 0.042). During follow-up, no differences could be identified regarding ICIQ-SF, PGI or I-QoL or number of pad usage.
Conclusions
The AdVance and AdVanceXP are safe and effective treatment options for male stress urinary incontinence. However, the innovations of the AdVanceXP sling did not demonstrate a superiority over the original AdVance sling regarding functional outcome.</description><subject>Aged</subject><subject>Chi-Square Distribution</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Nephrology</subject><subject>Oncology</subject><subject>Operative Time</subject><subject>Original Article</subject><subject>Patients</subject><subject>Prospective Studies</subject><subject>Quality of Life</subject><subject>Retrospective Studies</subject><subject>Suburethral Slings - adverse effects</subject><subject>Suburethral Slings - classification</subject><subject>Treatment Outcome</subject><subject>Urinary incontinence</subject><subject>Urinary Incontinence, Stress - therapy</subject><subject>Urology</subject><issn>0724-4983</issn><issn>1433-8726</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kEFLJDEQhYOs6Kz6A7xI2JOXXiuVdJLei4joriDoYRRvIZOu1paetCbTB_-9kdEVBE95JN97VXmM7Qv4LQDMUQaQqq5A2Aql0FW9wWZCSVlZg_oHm4FBVanGym32M-dHAGE01FtsGxuD1mg1Y_P5A_GT9tbHQNzH9kPfXfOlH4jnoY_3vI98Sn306aXIMMZVH6lAf3if-eqBUrHytu-6osr18S7b7PyQae_93GE352fz03_V5dXfi9OTyypII1aVboxSskFrtQjWL8IiiA4CKkGtFWA9kdKIXVmbTNc15MkKGSTUoBdaodxhh-vcpzQ-T5RXbtnnQMPgI41TdgiyRoXK6IL--oI-jlOKZTuHCGjqRjQFEmsopDHnRJ17Sv2y_NoJcG-Nu3XjrjTu3hp3dfEcvAdPiyW1_x0fFRcA10AuT_Ge0ufk71NfAUlDiRs</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>Hüsch, Tanja</creator><creator>Kretschmer, Alexander</creator><creator>Thomsen, Frauke</creator><creator>Kronlachner, Dominik</creator><creator>Kurosch, Martin</creator><creator>Obaje, Alice</creator><creator>Anding, Ralf</creator><creator>Kirschner-Hermanns, Ruth</creator><creator>Pottek, Tobias</creator><creator>Rose, Achim</creator><creator>Olianas, Roberto</creator><creator>Lusuardi, Lukas</creator><creator>Friedl, Alexander</creator><creator>Homberg, Roland</creator><creator>Pfitzenmaier, Jesco</creator><creator>Queissert, Fabian</creator><creator>Naumann, Carsten M.</creator><creator>Schweiger, Josef</creator><creator>Wotzka, Carola</creator><creator>Nyarangi-Dix, Joanne</creator><creator>Brehmer, Bernhard</creator><creator>Abdunnur, Rudi</creator><creator>Loertzer, Hagen</creator><creator>Ulm, Kurt</creator><creator>Hübner, Wilhelm</creator><creator>Bauer, Ricarda M.</creator><creator>Haferkamp, Axel</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7872-5496</orcidid></search><sort><creationdate>20181001</creationdate><title>The AdVance and AdVanceXP male sling in urinary incontinence: is there a difference?</title><author>Hüsch, Tanja ; Kretschmer, Alexander ; Thomsen, Frauke ; Kronlachner, Dominik ; Kurosch, Martin ; Obaje, Alice ; Anding, Ralf ; Kirschner-Hermanns, Ruth ; Pottek, Tobias ; Rose, Achim ; Olianas, Roberto ; Lusuardi, Lukas ; Friedl, Alexander ; Homberg, Roland ; Pfitzenmaier, Jesco ; Queissert, Fabian ; Naumann, Carsten M. ; Schweiger, Josef ; Wotzka, Carola ; Nyarangi-Dix, Joanne ; Brehmer, Bernhard ; Abdunnur, Rudi ; Loertzer, Hagen ; Ulm, Kurt ; Hübner, Wilhelm ; Bauer, Ricarda M. ; Haferkamp, Axel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-697443928861c8abcbc1f0c241ed8108aee4622f017e7ff9eae813c30506b6423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Chi-Square Distribution</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Nephrology</topic><topic>Oncology</topic><topic>Operative Time</topic><topic>Original Article</topic><topic>Patients</topic><topic>Prospective Studies</topic><topic>Quality of Life</topic><topic>Retrospective Studies</topic><topic>Suburethral Slings - adverse effects</topic><topic>Suburethral Slings - classification</topic><topic>Treatment Outcome</topic><topic>Urinary incontinence</topic><topic>Urinary Incontinence, Stress - therapy</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hüsch, Tanja</creatorcontrib><creatorcontrib>Kretschmer, Alexander</creatorcontrib><creatorcontrib>Thomsen, Frauke</creatorcontrib><creatorcontrib>Kronlachner, Dominik</creatorcontrib><creatorcontrib>Kurosch, Martin</creatorcontrib><creatorcontrib>Obaje, Alice</creatorcontrib><creatorcontrib>Anding, Ralf</creatorcontrib><creatorcontrib>Kirschner-Hermanns, Ruth</creatorcontrib><creatorcontrib>Pottek, Tobias</creatorcontrib><creatorcontrib>Rose, Achim</creatorcontrib><creatorcontrib>Olianas, Roberto</creatorcontrib><creatorcontrib>Lusuardi, Lukas</creatorcontrib><creatorcontrib>Friedl, Alexander</creatorcontrib><creatorcontrib>Homberg, Roland</creatorcontrib><creatorcontrib>Pfitzenmaier, Jesco</creatorcontrib><creatorcontrib>Queissert, Fabian</creatorcontrib><creatorcontrib>Naumann, Carsten M.</creatorcontrib><creatorcontrib>Schweiger, Josef</creatorcontrib><creatorcontrib>Wotzka, Carola</creatorcontrib><creatorcontrib>Nyarangi-Dix, Joanne</creatorcontrib><creatorcontrib>Brehmer, Bernhard</creatorcontrib><creatorcontrib>Abdunnur, Rudi</creatorcontrib><creatorcontrib>Loertzer, Hagen</creatorcontrib><creatorcontrib>Ulm, Kurt</creatorcontrib><creatorcontrib>Hübner, Wilhelm</creatorcontrib><creatorcontrib>Bauer, Ricarda M.</creatorcontrib><creatorcontrib>Haferkamp, Axel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>World journal of urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hüsch, Tanja</au><au>Kretschmer, Alexander</au><au>Thomsen, Frauke</au><au>Kronlachner, Dominik</au><au>Kurosch, Martin</au><au>Obaje, Alice</au><au>Anding, Ralf</au><au>Kirschner-Hermanns, Ruth</au><au>Pottek, Tobias</au><au>Rose, Achim</au><au>Olianas, Roberto</au><au>Lusuardi, Lukas</au><au>Friedl, Alexander</au><au>Homberg, Roland</au><au>Pfitzenmaier, Jesco</au><au>Queissert, Fabian</au><au>Naumann, Carsten M.</au><au>Schweiger, Josef</au><au>Wotzka, Carola</au><au>Nyarangi-Dix, Joanne</au><au>Brehmer, Bernhard</au><au>Abdunnur, Rudi</au><au>Loertzer, Hagen</au><au>Ulm, Kurt</au><au>Hübner, Wilhelm</au><au>Bauer, Ricarda M.</au><au>Haferkamp, Axel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The AdVance and AdVanceXP male sling in urinary incontinence: is there a difference?</atitle><jtitle>World journal of urology</jtitle><stitle>World J Urol</stitle><addtitle>World J Urol</addtitle><date>2018-10-01</date><risdate>2018</risdate><volume>36</volume><issue>10</issue><spage>1657</spage><epage>1662</epage><pages>1657-1662</pages><issn>0724-4983</issn><eissn>1433-8726</eissn><abstract>Purpose
To compare the efficacy and perioperative complications of the AdVanceXP with the original AdVance male sling.
Methods
We retrospectively enrolled 109 patients with an AdVance and 185 patients with an AdVanceXP male sling. The baseline characteristics and complication rates were analyzed retrospectively. Functional outcome and quality of life were evaluated prospectively by standardized, validated questionnaires. The Chi
2
-test for categorical and Mann–Whitney
U
test for continuous variables were performed to identify heterogeneity between the groups.
Results
Regarding operation time, there was no significant difference between the slings (
p
= 0.146). The complication rates were comparable in both groups except for postoperative urinary retention. This occurred significantly more often in patients with the AdVanceXP (
p
= 0.042). During follow-up, no differences could be identified regarding ICIQ-SF, PGI or I-QoL or number of pad usage.
Conclusions
The AdVance and AdVanceXP are safe and effective treatment options for male stress urinary incontinence. However, the innovations of the AdVanceXP sling did not demonstrate a superiority over the original AdVance sling regarding functional outcome.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>29728764</pmid><doi>10.1007/s00345-018-2316-5</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-7872-5496</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0724-4983 |
ispartof | World journal of urology, 2018-10, Vol.36 (10), p.1657-1662 |
issn | 0724-4983 1433-8726 |
language | eng |
recordid | cdi_proquest_miscellaneous_2035242476 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Aged Chi-Square Distribution Follow-Up Studies Humans Male Medicine Medicine & Public Health Nephrology Oncology Operative Time Original Article Patients Prospective Studies Quality of Life Retrospective Studies Suburethral Slings - adverse effects Suburethral Slings - classification Treatment Outcome Urinary incontinence Urinary Incontinence, Stress - therapy Urology |
title | The AdVance and AdVanceXP male sling in urinary incontinence: is there a difference? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-09T13%3A40%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20AdVance%20and%20AdVanceXP%20male%20sling%20in%20urinary%20incontinence:%20is%20there%20a%20difference?&rft.jtitle=World%20journal%20of%20urology&rft.au=H%C3%BCsch,%20Tanja&rft.date=2018-10-01&rft.volume=36&rft.issue=10&rft.spage=1657&rft.epage=1662&rft.pages=1657-1662&rft.issn=0724-4983&rft.eissn=1433-8726&rft_id=info:doi/10.1007/s00345-018-2316-5&rft_dat=%3Cproquest_cross%3E952253431%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=220275919&rft_id=info:pmid/29728764&rfr_iscdi=true |